Company Monitoring Page for Incyte

latest headlines for company on cafepharma

19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
Yahoo/Benzinga
Wed, 12/31/14 - 10:37 am
Tags:
biotech, Threshold Pharmaceuticals, Acceleron, Spectrum Pharmaceuticals, Ultragenyx, Argos Therapeutics, OncoMed, Peregrine Pharmaceuticals, Incyte, Calithera, Array Biopharma, Theravance, Puma Biotechnology, CTI BioPharma, Orexigen, Enanta Pharmaceuticals, Sucampo, Exelixis, Cubist Pharmaceuticals, United Therapeutics
Incyte's Jakafi Gets FDA Approval for Polycythemia Vera
Yahoo/Zacks.com
Fri, 12/5/14 - 12:16 pm
Tags:
Incyte, Jakafi, FDA, polycythemia vera
It Could be a Big December for Biotech ETFs
Yahoo/ETF Trends
Thu, 12/4/14 - 08:31 am
Tags:
biotech, ETFs, Incyte, Puma Biotechnology, Cubist Pharma
5 Critical Biotech Drug Dates and Events for December
24/7 Wall St
Mon, 12/1/14 - 04:45 pm
Tags:
biotech, Incyte, ruxolitinib, Cubist Pharma, ceftolozane/tazobactam, Biocryst, peramivir, Vertex Pharmaceuticals, Kalydeco, Pozen, PA8140/PA32540
Incyte Building Blockbuster Drug One Disease At A Time
Investors.com
Mon, 11/17/14 - 04:05 pm
Tags:
Incyte, Jakafi, myelofibrosis
1 Biotech Beast Worth Tracking
Yahoo/Benzinga
Wed, 11/12/14 - 04:37 pm
Tags:
Incyte, Merck, Novartis, Eli Lilly, Pfizer
Incyte's Jakafi Unlikely to Benefit Pancreatic Cancer Patients
TheStreet.com
Wed, 06/11/14 - 10:38 am
Tags:
Incyte, Jakafi, pancreatic cancer
Incyte Gains on Positive Jakafi Data
Yahoo/Zacks.com
Wed, 06/4/14 - 02:53 pm
Tags:
Incyte, Jakafi, polycythemia vera, ASCO
Incyte's 'IDO' Cancer Immunotherapy Causes Investor Scrum at ASCO '14
TheStreet.com
Mon, 06/2/14 - 06:09 pm
Tags:
Incyte, ASCO, immunotherapy, melanoma, INCB024360
Bristol-Myers, Incyte enter collaboration agreement for nivolumab, INCB24360
The Fly on the Wall
Tue, 05/27/14 - 09:14 am
Tags:
Bristol-Myers Squibb, Incyte, nivolumab, melanoma, non-small cell lung cancer, colorectal cancer, ovarian cancer, INCB24360
Three Companies That Want to Cure Pancreatic Cancer
Yahoo/247WallStreet
Thu, 05/22/14 - 10:10 am
Tags:
pancreatic cancer, Celgene, Abraxane, Incyte, ruxolitinib, Merrimack Pharmaceuticals, MM-398
The Zacks Analyst Blog Highlights: Incyte, Celldex, Bristol-Myers, AstraZeneca and Halozyme
Yahoo/Zacks.com
Thu, 05/22/14 - 08:36 am
Tags:
Incyte, Celldex, Bristol-Myers Squibb, AstraZeneca, Halozyme
AstraZeneca and Incyte to study cancer drugs together
Yahoo/Reuters
Wed, 05/14/14 - 08:18 am
Tags:
AstraZeneca, Incyte, cancer, R&D
Show me the money: Which drugs made the top 10 list on upfront deals?
Fierce Biotech
Mon, 05/12/14 - 09:36 am
Tags:
biotech, GED-0301, Celgene, Nogra Pharma, AbbVie, Reata, Bardoxolone, Abbott Labs, Tradjenta, Eli Lilly, Boehringer Ingelheim, FG-4592, AstraZeneca, FibroGen, Pfizer, Bristol-Myers Squibb, Eliquis, Moderna, Forma Therapeutics, dimebon, Medivation, Jakafi, Novartis, Incyte
Gilead: X-Marks The Spot For Sovaldi Sales
Seeking Alpha
Wed, 04/23/14 - 10:18 am
Tags:
Gilead Sciences, Sovaldi, hepatitis C, Incyte, Clovis Oncology, Puma Biotechnology
Does This Stock Warrant a $9 Billion Market Cap?
Motley Fool
Sat, 03/29/14 - 09:11 am
Tags:
Incyte
Incyte May Be Undervalued Even After Rise, New CEO Says
Bloomberg
Sat, 02/22/14 - 10:49 am
Tags:
Incyte
Incyte's new CEO says his pipeline is underrated--and undervalued
Fierce Biotech
Fri, 02/21/14 - 09:36 am
Tags:
Incyte, Pharma CEOs, Hervé Hoppenot
Incyte Shows Its Path Towards Growth
Seeking Alpha
Thu, 02/13/14 - 09:31 am
Tags:
Incyte, Jakafi
Frantic Pace In Cancer Immunotherapy: Merck Vs. Bristol-Myers
Seeking Alpha
Wed, 02/12/14 - 09:14 am
Tags:
cancer immunotherapy, Merck, Bristol-Myers Squibb, Amgen, Incyte, Pfizer, MK-3475, Ablynx, Yervoy

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.